Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A

Date
2015
Author
Mercan, Ridvan
Kasifoglu, Timuin
Akar, Servet
Inanc, Nevsun
Yildiz, Fatih
Kucuksahin, Orhan
Karadag, Omer
Bes, Cemal
YAZISIZ, VELİ
Yilmazer, Baris
Ozmen, Mustafa
Erten, Sukran
Senel, Soner
Yazici, Ayten
Kalfa, Melike
KİRAZ, SEDAT
Direskeneli, Haner
ERKEN, EREN
Turgay, Murat
ÖZTÜRK, MEHMET AKİF
Soy, Mehmet
AKSU, KENAN
Dinc, Ayhan
Ertenli, Ihsan
Kisacik, Bunyamin
Pehlivan, Yavuz
KILIÇ, LEVENT
Simsek, Ismail
ÇEFLE, AYŞE
AKKOÇ, NURULLAH
Tascilar, Koray
KALYONCU, UMUT
Emmungil, Hakan
Onat, Ahmet Mesut
Yilmaz, Sedat
Metadata
Show full item record
Abstract
Objective: The reactivation of hepatitis B virus (HBV) infection is a well-known event in hepatitis B surface antigen (HbsAg)-positive patients receiving immunosuppressive therapy. The objective of this study was to assess the antiviral practice and course of HBV infection in inflammatory arthritis.
URI
http://hdl.handle.net/20.500.12627/126952
https://doi.org/10.5152/eurjrheum.2015.0111
Collections